Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase 1 Study of Anti-FLT3 Chimeric Antigen Receptor-redirected T Cells in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)

This is a phase 1 dose escalation study to determine the safety of anti-FLT3 CAR-T in subjects with R/R AML. The primary objective is to assess safety. Up to 1…

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Hemogenyx Pharmaceuticals LLCNCT06786533